We are actively pursuing new agents to treat sickle cell disease as well as new approaches to alleviate the physical and emotional suffering. Our goal, in partnership with prominent scientists at the Albert Einstein College of Medicine, is to find new cures for sickle cell disease. Our patients have the opportunity to be actively involved in federally funded national clinical trials to explore new treatment methods. These include new anti-adhesive and anti-inflammatory therapies for the treatment of pain crises, stroke prevention, strategies for improved adherence to medication and transition to adult care.